Matches in Nanopublications for { ?s ?p "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP293651.RAKup862CpfZOxbTsw4btAh2tGjsA-hrbokMPQoKURRCY130_assertion description "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293651.RAKup862CpfZOxbTsw4btAh2tGjsA-hrbokMPQoKURRCY130_provenance.
- assertion description "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_assertion description "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500675.RAtD44PlbL7rssJfN6COZngJRNwUdm6gg8RHyfojfpQio130_provenance.
- NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_assertion description "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785847.RAF2Jl78mgH8cqZaib_kVT1zdrF4cM1Cj2jyF0HYeMQ_A130_provenance.
- NP785879.RA5zBbv8b7QQB0OPetw4-XqN_AIfBER-XEg2f0TQ_rxyo130_assertion description "[We conclude that DEK-CAN molecular monitoring by RQ-PCR in t(6;9) malignancies is a useful tool for individual patient management and that molecular negativity is indispensable for survival, but should not be a prerequisite for allografting in this rare, poor prognosis, subset of AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785879.RA5zBbv8b7QQB0OPetw4-XqN_AIfBER-XEg2f0TQ_rxyo130_provenance.